653P Baseline and 3 Weeks On-Treatment Plasma EGFR Mutation (egfrm) Dynamics in Patients with EGFR Mutant Advanced NSCLC Treated with First-Line Osimertinib: A Prospective, Multi-Center, Real-World Analysis
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要